The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)

Michal Steffl,1 Jan Sima,2 Kate Shiells,3 Iva Holmerova3 1Department of Physiology and Biochemistry, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic; 2Department of Sport Management, Faculty of Physical Education and Sport, Charles University, Prague, Czech Repub...

Full description

Bibliographic Details
Main Authors: Steffl M, Sima J, Shiells K, Holmerova I
Format: Article
Language:English
Published: Dove Medical Press 2017-11-01
Series:Clinical Interventions in Aging
Subjects:
Online Access:https://www.dovepress.com/the-increase-in-health-care-costs-associated-with-muscle-weakness-in-o-peer-reviewed-article-CIA
_version_ 1819129676290850816
author Steffl M
Sima J
Shiells K
Holmerova I
author_facet Steffl M
Sima J
Shiells K
Holmerova I
author_sort Steffl M
collection DOAJ
description Michal Steffl,1 Jan Sima,2 Kate Shiells,3 Iva Holmerova3 1Department of Physiology and Biochemistry, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic; 2Department of Sport Management, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic; 3Centre of Expertise in Longevity and Long-term Care, Faculty of Humanities, Charles University, Prague, Czech Republic Abstract: Muscle weakness and associated diseases are likely to place a considerable economic burden on government health care expenditure. Therefore, our aim for this study was to estimate the direct and indirect costs associated with muscle weakness in the Czech Republic. We applied a cost-of-illness approach using data from the Survey of Health, Ageing and Retirement in Europe (SHARE). Six hundred and eighty-nine participants aged 70 years and over and without any long-term illnesses were included in our study. A generalized linear model with gamma distribution was used, and odds ratio (OR) was calculated in order to explore the effect of muscle weakness on direct and indirect costs. For both genders, muscle weakness had a statistically significant impact on direct costs (OR =2.11), but did not have a statistically significant impact on indirect costs (OR =1.08) or on total cost (OR =1.51). Muscle weakness had the greatest statistically significant impact on direct costs in females (OR =2.75). In conclusion, our study has shown that muscle weakness may lead to increased direct costs, and consequently place a burden on health care expenditure. Therefore, the results of this study could lead to greater interest in the prevention of muscle weakness among older people in the Czech Republic. Keywords: direct cost, indirect cost, economic burden, sarcopenia, frailty
first_indexed 2024-12-22T08:47:30Z
format Article
id doaj.art-bab4f6f6ee4e499cbd0b226cc44fe395
institution Directory Open Access Journal
issn 1178-1998
language English
last_indexed 2024-12-22T08:47:30Z
publishDate 2017-11-01
publisher Dove Medical Press
record_format Article
series Clinical Interventions in Aging
spelling doaj.art-bab4f6f6ee4e499cbd0b226cc44fe3952022-12-21T18:32:04ZengDove Medical PressClinical Interventions in Aging1178-19982017-11-01Volume 122003200735739The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)Steffl MSima JShiells KHolmerova IMichal Steffl,1 Jan Sima,2 Kate Shiells,3 Iva Holmerova3 1Department of Physiology and Biochemistry, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic; 2Department of Sport Management, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic; 3Centre of Expertise in Longevity and Long-term Care, Faculty of Humanities, Charles University, Prague, Czech Republic Abstract: Muscle weakness and associated diseases are likely to place a considerable economic burden on government health care expenditure. Therefore, our aim for this study was to estimate the direct and indirect costs associated with muscle weakness in the Czech Republic. We applied a cost-of-illness approach using data from the Survey of Health, Ageing and Retirement in Europe (SHARE). Six hundred and eighty-nine participants aged 70 years and over and without any long-term illnesses were included in our study. A generalized linear model with gamma distribution was used, and odds ratio (OR) was calculated in order to explore the effect of muscle weakness on direct and indirect costs. For both genders, muscle weakness had a statistically significant impact on direct costs (OR =2.11), but did not have a statistically significant impact on indirect costs (OR =1.08) or on total cost (OR =1.51). Muscle weakness had the greatest statistically significant impact on direct costs in females (OR =2.75). In conclusion, our study has shown that muscle weakness may lead to increased direct costs, and consequently place a burden on health care expenditure. Therefore, the results of this study could lead to greater interest in the prevention of muscle weakness among older people in the Czech Republic. Keywords: direct cost, indirect cost, economic burden, sarcopenia, frailtyhttps://www.dovepress.com/the-increase-in-health-care-costs-associated-with-muscle-weakness-in-o-peer-reviewed-article-CIAdirect costindirect costeconomic burdensarcopeniafrailty
spellingShingle Steffl M
Sima J
Shiells K
Holmerova I
The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)
Clinical Interventions in Aging
direct cost
indirect cost
economic burden
sarcopenia
frailty
title The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)
title_full The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)
title_fullStr The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)
title_full_unstemmed The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)
title_short The increase in health care costs associated with muscle weakness in older people without long-term illnesses in the Czech Republic: results from the Survey of Health, Ageing and Retirement in Europe (SHARE)
title_sort increase in health care costs associated with muscle weakness in older people without long term illnesses in the czech republic results from the survey of health ageing and retirement in europe share
topic direct cost
indirect cost
economic burden
sarcopenia
frailty
url https://www.dovepress.com/the-increase-in-health-care-costs-associated-with-muscle-weakness-in-o-peer-reviewed-article-CIA
work_keys_str_mv AT stefflm theincreaseinhealthcarecostsassociatedwithmuscleweaknessinolderpeoplewithoutlongtermillnessesintheczechrepublicresultsfromthesurveyofhealthageingandretirementineuropeshare
AT simaj theincreaseinhealthcarecostsassociatedwithmuscleweaknessinolderpeoplewithoutlongtermillnessesintheczechrepublicresultsfromthesurveyofhealthageingandretirementineuropeshare
AT shiellsk theincreaseinhealthcarecostsassociatedwithmuscleweaknessinolderpeoplewithoutlongtermillnessesintheczechrepublicresultsfromthesurveyofhealthageingandretirementineuropeshare
AT holmerovai theincreaseinhealthcarecostsassociatedwithmuscleweaknessinolderpeoplewithoutlongtermillnessesintheczechrepublicresultsfromthesurveyofhealthageingandretirementineuropeshare
AT stefflm increaseinhealthcarecostsassociatedwithmuscleweaknessinolderpeoplewithoutlongtermillnessesintheczechrepublicresultsfromthesurveyofhealthageingandretirementineuropeshare
AT simaj increaseinhealthcarecostsassociatedwithmuscleweaknessinolderpeoplewithoutlongtermillnessesintheczechrepublicresultsfromthesurveyofhealthageingandretirementineuropeshare
AT shiellsk increaseinhealthcarecostsassociatedwithmuscleweaknessinolderpeoplewithoutlongtermillnessesintheczechrepublicresultsfromthesurveyofhealthageingandretirementineuropeshare
AT holmerovai increaseinhealthcarecostsassociatedwithmuscleweaknessinolderpeoplewithoutlongtermillnessesintheczechrepublicresultsfromthesurveyofhealthageingandretirementineuropeshare